KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Non-Current Deffered Revenue (2018 - 2025)

Historic Non-Current Deffered Revenue for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$50.9 million.

  • BioNTech SE's Non-Current Deffered Revenue fell 7278.27% to -$50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.9 million, marking a year-over-year decrease of 7278.27%. This contributed to the annual value of $195.6 million for FY2024, which is 5439.13% down from last year.
  • As of Q3 2025, BioNTech SE's Non-Current Deffered Revenue stood at -$50.9 million, which was down 7278.27% from -$37.4 million recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Non-Current Deffered Revenue peaked at $428.8 million during Q4 2023, and registered a low of -$50.9 million during Q3 2025.
  • Its 5-year average for Non-Current Deffered Revenue is $31.3 million, with a median of -$3.2 million in 2023.
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first soared by 76829.15% in 2023, then tumbled by 80123.53% in 2024.
  • BioNTech SE's Non-Current Deffered Revenue (Quarter) stood at $10.3 million in 2021, then soared by 379.62% to $49.4 million in 2022, then soared by 768.29% to $428.8 million in 2023, then crashed by 54.39% to $195.6 million in 2024, then crashed by 126.01% to -$50.9 million in 2025.
  • Its Non-Current Deffered Revenue was -$50.9 million in Q3 2025, compared to -$37.4 million in Q2 2025 and -$15.3 million in Q1 2025.